381 related articles for article (PubMed ID: 26391046)
21. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
[TBL] [Abstract][Full Text] [Related]
22. Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.
Powers BE; Velazquez R; Kelley CM; Ash JA; Strawderman MS; Alldred MJ; Ginsberg SD; Mufson EJ; Strupp BJ
Brain Struct Funct; 2016 Dec; 221(9):4337-4352. PubMed ID: 26719290
[TBL] [Abstract][Full Text] [Related]
23. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.
Granholm AC; Ford KA; Hyde LA; Bimonte HA; Hunter CL; Nelson M; Albeck D; Sanders LA; Mufson EJ; Crnic LS
Physiol Behav; 2002 Nov; 77(2-3):371-85. PubMed ID: 12419414
[TBL] [Abstract][Full Text] [Related]
24. Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Aβ42 deposition in AppNL-G-F Alzheimer's disease model mice.
Bellio TA; Laguna-Torres JY; Campion MS; Chou J; Yee S; Blusztajn JK; Mellott TJ
PLoS One; 2024; 19(2):e0297289. PubMed ID: 38315685
[TBL] [Abstract][Full Text] [Related]
25. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice.
Kern DS; Maclean KN; Jiang H; Synder EY; Sladek JR; Bjugstad KB
Cell Transplant; 2011; 20(3):371-9. PubMed ID: 20875225
[TBL] [Abstract][Full Text] [Related]
26. Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice.
Yan J; Ginsberg SD; Powers B; Alldred MJ; Saltzman A; Strupp BJ; Caudill MA
FASEB J; 2014 Oct; 28(10):4312-23. PubMed ID: 24963152
[TBL] [Abstract][Full Text] [Related]
27. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
[TBL] [Abstract][Full Text] [Related]
28. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
29. Prenatal treatment with preimplantation factor improves early postnatal neurogenesis and cognitive impairments in a mouse model of Down syndrome.
Moreau M; Dard R; Madani A; Kandiah J; Kassis N; Ziga J; Castiglione H; Day S; Bourgeois T; Matrot B; Vialard F; Janel N
Cell Mol Life Sci; 2024 May; 81(1):215. PubMed ID: 38739166
[TBL] [Abstract][Full Text] [Related]
30. The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice.
Ahmed MM; Wang AC; Elos M; Chial HJ; Sillau S; Solano DA; Coughlan C; Aghili L; Anton P; Markham N; Adame V; Gardiner KJ; Boyd TD; Potter H
Neurobiol Dis; 2022 Jun; 168():105694. PubMed ID: 35307513
[TBL] [Abstract][Full Text] [Related]
31. Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.
Day SM; Yang W; Wang X; Stern JE; Zhou X; Macauley SL; Ma T
eNeuro; 2019; 6(2):. PubMed ID: 31040160
[TBL] [Abstract][Full Text] [Related]
32. Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.
Alldred MJ; Lee SH; Petkova E; Ginsberg SD
J Comp Neurol; 2015 Jan; 523(1):61-74. PubMed ID: 25131634
[TBL] [Abstract][Full Text] [Related]
33. The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome.
Stagni F; Uguagliati B; Emili M; Giacomini A; Bartesaghi R; Guidi S
Sci Rep; 2021 Mar; 11(1):6300. PubMed ID: 33737521
[TBL] [Abstract][Full Text] [Related]
34. RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome.
Hamlett ED; Hjorth E; Ledreux A; Gilmore A; Schultzberg M; Granholm AC
Glia; 2020 Jul; 68(7):1347-1360. PubMed ID: 31944407
[TBL] [Abstract][Full Text] [Related]
35. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.
Parrini M; Ghezzi D; Deidda G; Medrihan L; Castroflorio E; Alberti M; Baldelli P; Cancedda L; Contestabile A
Sci Rep; 2017 Dec; 7(1):16825. PubMed ID: 29203796
[TBL] [Abstract][Full Text] [Related]
36. Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice.
Rueda N; Vidal V; García-Cerro S; Narcís JO; Llorens-Martín M; Corrales A; Lantigua S; Iglesias M; Merino J; Merino R; Martínez-Cué C
Brain Behav Immun; 2018 Oct; 73():235-251. PubMed ID: 29758264
[TBL] [Abstract][Full Text] [Related]
37. Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21.
Cannavo C; Tosh J; Fisher EMC; Wiseman FK
Prog Brain Res; 2020; 251():181-208. PubMed ID: 32057307
[TBL] [Abstract][Full Text] [Related]
38. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.
Nakano-Kobayashi A; Awaya T; Kii I; Sumida Y; Okuno Y; Yoshida S; Sumida T; Inoue H; Hosoya T; Hagiwara M
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10268-10273. PubMed ID: 28874550
[TBL] [Abstract][Full Text] [Related]
39. Lithium rescues synaptic plasticity and memory in Down syndrome mice.
Contestabile A; Greco B; Ghezzi D; Tucci V; Benfenati F; Gasparini L
J Clin Invest; 2013 Jan; 123(1):348-61. PubMed ID: 23202733
[TBL] [Abstract][Full Text] [Related]
40. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
